• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于泛癌症生物信息学的 TRPM7 在癌症中的文献综述。

A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers.

机构信息

Department of Anesthesiology, Health Science Center, Stony Brook University, Stony Brook, NY 11794, USA.

Department of Anesthesiology, Health Science Center, Stony Brook University, Stony Brook, NY 11794, USA.

出版信息

Pharmacol Ther. 2022 Dec;240:108302. doi: 10.1016/j.pharmthera.2022.108302. Epub 2022 Nov 1.

DOI:10.1016/j.pharmthera.2022.108302
PMID:36332746
Abstract

TRPM7, a divalent cation-selective channel with kinase domains, has been widely reported to potentially affect cancers. In this study, we conducted multiple bioinformatic analyses based on open databases and reviewed articles that provided evidence for the effects of TRPM7 on cancers. The purposes of this paper are 1) to provide a pan-cancer overview of TRPM7 in cancers; 2) to summarize evidence of TRPM7 effects on cancers; 3) to identify potential future studies of TRPM7 in cancer. Bioinformatics analysis revealed that no cancer-related TRPM7 mutation was found. TRPM7 is aberrantly expressed in most cancer types but the cancer-noncancer expression pattern varies across cancer types. TRPM7 was not associated with survival, TMB, or cancer stemness in most cancer types. TRPM7 affected drug sensitivity and tumor immunity in some cancer types. The in vitro evidence, preclinical in vivo evidence, and clinical evidence for TRPM7 effects on cancers as well as TRPM7 kinase substrate and TRPM7-targeting drugs associated with cancers were summarized to facilitate comparison. We matched the bioinformatics evidence to literature evidence, thereby unveiling potential avenues for future investigation of TRPM7 in cancers. We believe that this paper will help orient research toward important and relevant aspects of the role of TRPM7 in cancers.

摘要

TRPM7 是一种具有激酶结构域的二价阳离子选择性通道,广泛报道其可能影响癌症。在这项研究中,我们基于公开数据库进行了多项生物信息学分析,并回顾了提供 TRPM7 对癌症影响证据的文章。本文的目的是:1)提供癌症中 TRPM7 的泛癌概述;2)总结 TRPM7 对癌症影响的证据;3)确定 TRPM7 在癌症中未来研究的潜力。生物信息学分析显示,未发现与癌症相关的 TRPM7 突变。TRPM7 在大多数癌症类型中异常表达,但癌症-非癌症表达模式在不同癌症类型之间存在差异。在大多数癌症类型中,TRPM7 与生存、TMB 或癌症干性无关。TRPM7 影响某些癌症类型的药物敏感性和肿瘤免疫。本文总结了 TRPM7 对癌症影响的体外证据、临床前体内证据和临床证据,以及与癌症相关的 TRPM7 激酶底物和 TRPM7 靶向药物,以方便比较。我们将生物信息学证据与文献证据相匹配,从而揭示了未来研究 TRPM7 在癌症中的潜在途径。我们相信,本文将有助于将研究方向导向 TRPM7 在癌症中作用的重要和相关方面。

相似文献

1
A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers.基于泛癌症生物信息学的 TRPM7 在癌症中的文献综述。
Pharmacol Ther. 2022 Dec;240:108302. doi: 10.1016/j.pharmthera.2022.108302. Epub 2022 Nov 1.
2
Modulators of TRPM7 and its potential as a drug target for brain tumours.TRPM7 的调节剂及其作为脑肿瘤药物靶点的潜力。
Cell Calcium. 2022 Jan;101:102521. doi: 10.1016/j.ceca.2021.102521. Epub 2021 Dec 17.
3
Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.TRPM7 通道酶致癌作用的最新进展
Curr Med Chem. 2016;23(36):4092-4107. doi: 10.2174/0929867323666160907162002.
4
The Role of TRPM7 in Oncogenesis.TRPM7 在肿瘤发生中的作用。
Int J Mol Sci. 2024 Jan 5;25(2):719. doi: 10.3390/ijms25020719.
5
Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.瞬时受体电位香草酸亚型7通道在恶性肿瘤中的致癌作用及治疗靶点
Expert Opin Ther Targets. 2014 Oct;18(10):1177-96. doi: 10.1517/14728222.2014.940894. Epub 2014 Jul 29.
6
Clinical and Prognostic Values of TRPM7 in Colon and Rectal Cancers.TRPM7 在结肠癌和直肠癌中的临床及预后价值。
Medicina (Kaunas). 2022 Nov 2;58(11):1582. doi: 10.3390/medicina58111582.
7
TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90α/uPA/MMP2 signaling pathway.TRPM7 过表达通过调节热休克蛋白 90α/uPA/MMP2 信号通路增强肺癌的癌症干细胞样和转移表型。
BMC Cancer. 2018 Nov 26;18(1):1167. doi: 10.1186/s12885-018-5050-x.
8
TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.瞬时受体电位阳离子通道亚家族M成员7(TRPM7)在膀胱癌中过表达,并促进细胞增殖、迁移、侵袭及肿瘤生长。
Oncol Rep. 2017 Oct;38(4):1967-1976. doi: 10.3892/or.2017.5883. Epub 2017 Aug 7.
9
Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.瞬时受体电位 melastatin 相关 7 型(TRPM7)启动子甲基化可预测 Luminal A 型乳腺癌患者的预后更好。
BMC Cancer. 2022 Sep 5;22(1):951. doi: 10.1186/s12885-022-10038-z.
10
TRPM7 and its role in neurodegenerative diseases.瞬时受体电位阳离子通道亚家族M成员7(TRPM7)及其在神经退行性疾病中的作用。
Channels (Austin). 2015;9(5):253-61. doi: 10.1080/19336950.2015.1075675. Epub 2015 Jul 28.

引用本文的文献

1
FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathway.FAM49B通过激活PI3K/AKT信号通路介导胃癌的肿瘤进展和不良预后。
J Mol Histol. 2025 Sep 3;56(5):291. doi: 10.1007/s10735-025-10589-y.
2
Investigating the relationship between peripheral blood transferrin receptor protein and tumor cell ferroptosis, invasion, and metastasis in bladder cancer.研究外周血转铁蛋白受体蛋白与膀胱癌肿瘤细胞铁死亡、侵袭和转移之间的关系。
Sci Rep. 2025 Sep 1;15(1):32197. doi: 10.1038/s41598-025-12187-0.
3
Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway.
PIGU基因沉默通过PI3K/AKT信号通路抑制食管鳞状细胞癌的进展。
Sci Rep. 2025 Aug 25;15(1):31237. doi: 10.1038/s41598-025-08748-y.
4
The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637.长链非编码RNA PANDAR在胃癌中的诊断和预测价值及其通过miR-637对胃癌进展的调控
Hereditas. 2025 Jul 26;162(1):144. doi: 10.1186/s41065-025-00511-7.
5
FLNA, a disulfidptosis-related gene, modulates tumor immunity and progression in colorectal cancer.FLNA是一种与铁死亡相关的基因,可调节结直肠癌的肿瘤免疫和进展。
Cell Mol Biol Lett. 2025 Jul 26;30(1):92. doi: 10.1186/s11658-025-00761-3.
6
MT1JP/miR-103a-3p induce pyroptosis and regulate the tumor immune microenvironment in gastric cancer.MT1JP/miR-103a-3p诱导胃癌细胞焦亡并调节肿瘤免疫微环境。
Sci Rep. 2025 Jul 23;15(1):26799. doi: 10.1038/s41598-025-10361-y.
7
Pan-cancer analysis of enhancer-induced MIR17HG and validation as a SIRT1-promoting factor in colorectal cancer.增强子诱导的MIR17HG的泛癌分析及其作为结直肠癌中促进SIRT1因子的验证
Med Oncol. 2025 Jun 30;42(8):299. doi: 10.1007/s12032-025-02841-y.
8
Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus.经动脉化疗栓塞联合乐伐替尼加或不加蛋白-1抑制剂治疗伴有门静脉癌栓的肝细胞癌
World J Clin Oncol. 2025 Jun 24;16(6):106798. doi: 10.5306/wjco.v16.i6.106798.
9
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis.全面的泛癌分析和实验验证表明,FCHSD1是一种用于诊断、免疫浸润和预后的潜在生物标志物。
Front Oncol. 2025 Jun 4;15:1547067. doi: 10.3389/fonc.2025.1547067. eCollection 2025.
10
Natural killer cell dysfunction is associated with colorectal cancer with severe COVID-19.自然杀伤细胞功能障碍与患有严重新型冠状病毒肺炎的结直肠癌有关。
World J Gastrointest Oncol. 2025 May 15;17(5):104591. doi: 10.4251/wjgo.v17.i5.104591.